Clinical Trial

Plasma Exchange in Pediatric Autoimmune Encephalitis

Study acronym: PE/AIE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study will be to compare the efficacy of daily plasma exchange (PLEX) versus alternate-day PLEX in achieving a favorable functional outcome in children with autoimmune encephalitis. The study population will be divided into two groups, the first group will perform PLEX on consecutive days and the second one will perform it every other day. Then, A Favorable functional outcome measure defined as modified Rankin Scale (mRS) score ≤ 2. The mRS will be assessed by a blinded assessor at the end of the sessions to determine which method has superior efficacy in treatment of autoimmune encephalitis.
Trial Details
NCT Number NCT07707739
Lead Sponsor Menoufia University
Conditions Autoimmune Encephalitis (AE)
Enrollment 22 participants
Start Date 2026-08-01
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-16